Skip to main content

Dr. Niklas Klümper

Member

Department of Urology and Institute of Experimental Oncology

niklas.kluemper@ukbonn.de

+49 228 28751394

Website

PD Dr. med. Niklas Klümper, an advanced clinician-scientist in the ACCENT program at the University Hospital Bonn, focuses on uro-oncology and aims to improve treatment response predictions for targeted therapies, leading to more personalized approaches for uro-oncological diseases. His team has pioneered the prediction of immune checkpoint blockade responses through the analysis of longitudinal inflammatory markers, contributing to the field of immuno-oncology. They are also investigating the mechanisms of resistance to antibody-drug conjugates in patients with metastatic urothelial carcinoma, an emerging area of oncological therapies, and aim to improve precision oncology by tailoring treatment to the molecular profile of patients.

Niklas Klümper

Recent publications

  • [Management of BK polyomavirus (BKPyV) in German urological kidney transplant centers].

    Urologie (Heidelberg, Germany)

    Authors: Yana Terziyska, Niklas Klümper, Hagen Ehleiter, Georgious Gakis, Juliane Putz, Julian Stumpf, Oliver Hakenberg, Karoline Kernig, Anna Sophia Kienel, Philip Zeuschner, Karina Siedenburg, Jonas Beckmann, Isabel Lichy, Laila Schneidewind

  • Endothelial p16 expression identifies a subgroup of clear cell renal cell carcinoma with favorable prognosis.

    BMC cancer

    Authors: Michael Stoffel, Katharina Baschun, Melina Kehl, Jörg Ellinger, Niklas Klümper, Sebastian Kadzik, Franziska I Winterhagen, Manuel Ritter, Michael Hölzel, Glen Kristiansen, Marieta I Toma

  • Accumulating Evidence Supports NECTIN4 as a Predictive Biomarker for Enfortumab Vedotin: The Compartment Still Matters.

    European urology

    Authors: Niklas Klümper, Jonathan E Rosenberg, David H Aggen, Markus Eckstein

All publications by Dr. Niklas Klümper